Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 58 filings·Updated 3 Oct 2026
Showing 10 of 58 filings.
3 Oct 20261 filing
Company UpdateNewspaper Publication

Intimation under Regulation 30 of SEBI (LODR),2015 for Newspaper publication regarding issuance of postal ballot notice for appointment of Mr. Prabhakar Raghunath Zavar as Independent Director.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:22View Source
28 Sept 20261 filing
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Mangalam Drugs & Organics: Not a Large Corporate; Annexure-A Initial Disclosure Filed

Filing Status

  • Not a Large Corporate under SEBI circular as of 31 March 2026.
  • Outstanding borrowings as on 31 March 2026: Rs 749.76 lakhs.
  • Highest credit rating during the previous FY: CRISIL-D.
  • Annexure-A contains the initial disclosure.
Filed 11:55View Source
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Mangalam Drugs & Organics Ltd – Trading Window Closure Notice

Mangalam Drugs & Organics Ltd – Trading Window Closure Notice

Filed 12:03View Source
24 Sept 20263 filings
Company UpdateChange in Auditors

Mangalam Drugs & Organics appoints new Secretarial Auditor and two new Statutory Auditors; retirement of current Statutory Auditor

Audit appointments

  • 53rd AGM approved L.N. Joshi & Co as Secretarial Auditor for five years.
  • SN Nanda & Co appointed Statutory Auditor for five years from 53rd to 58th AGM.
  • V.S. Somani & Co retired as Statutory Auditor after term completion.
Filed 18:33View Source
AGM/EGMAGM

Mangalam Drugs and Organics holds 53rd AGM via VC/OAVM; financials adopted and key governance actions approved

AGM Details

  • AGM held on 23 September 2026 via VC/OAVM; venue deemed at registered office.

Key Resolutions

  • Ordinary: Adopt standalone and consolidated financial statements for year ended 31 March 2026.
  • Ordinary: Re-appoint Govardhan Murlidhar Dhoot as Executive Director (retiring by rotation).
  • Ordinary: Appoint and fix remuneration of Statutory and Cost Auditors for 2026-27.
  • Ordinary: Approve material related party transactions.
  • Special: Appoint L. N. Joshi & Co. as Secretarial Auditor from this AGM to 58th AGM.

Voting Results

  • Item 1: Passed with ~99.99% in favour; minimal dissent.
  • Item 2: Passed with ~99.97% in favour; minimal dissent.
  • Item 3: Passed; remuneration of auditors approved.
  • Item 5: Passed; material related party transactions approved.
  • Item 6: Passed; Secretarial Auditor appointed for term.

Auditors & Directors

  • Statutory and Cost Auditor remuneration approved for 2026-27.
  • Secretarial Auditor: L. N. Joshi & Co. appointed from AGM to 58th AGM.

Material Related Party Transactions

  • Material RPTs with related parties approved; details not disclosed in excerpt.
Filed 18:03View Source
AGM/EGMAGM

Mangalam Drugs and Organics 53rd AGM approves financials, ED re-appointment, audits, RPTs, and secretarial audit

AGM Details

  • Date: 23 September 2026; mode: physical with VC/OAVM facility at registered office.
  • Venue: Registered Office; meeting deemed to be held there.
  • Remote e-voting window: 19–22 September 2026; cut-off date: 16 September 2026.

Key Resolutions

  • Adopt standalone and consolidated financial statements for year ended 31 March 2026.
  • Re-appoint Govardhan M. Dhoot as Executive Director (rotates).
  • Appoint S.N. Nanda & Co. as statutory auditors for five years; fix remuneration.
  • Ratify remuneration payable to Rampurawala Mohammed A. Co. as Cost Auditors.
  • Approve material related party transactions.
  • Appoint L. N. Joshi & Co. as Secretarial Auditors from 53rd to 58th AGM.

Voting Results

  • Item 1 passed with ~99.985% in favour.
  • Item 2 passed with ~99.97% in favour.
  • Item 3 passed with ~99.99% in favour.
  • Item 4 passed with ~99.99% in favour.
  • Item 5 passed with ~82.36% in favour; promoter-group abstentions noted.
  • Item 6 passed with ~99.99% in favour.

Dividend

  • No dividend proposed or declared.

Directors & Auditors

  • Executive Director re-appointed; term not disclosed.
  • Statutory Auditors appointed for five years; remuneration fixed.
  • Cost Auditors remuneration ratified.
  • Secretarial Auditors appointed from 53rd AGM to 58th AGM.

Related Party Transactions

  • Material related party transactions approved with promoter group as counterparty; value undisclosed.

Other Approvals

  • No other material business disclosed.
Filed 17:54View Source
23 Sept 20261 filing
AGM/EGMAGM

Mangalam Drugs holds 53rd AGM via VC; approves financials, ED re-appointment, auditors, cost audit remuneration and RPTs

AGM Details

  • Date and time: 23 September 2026, 3:00–4:00 PM IST.
  • Mode: VC/OAVM; concluded at 4:00 PM IST.
  • Cut-off date for members: 16 September 2026.
  • Remote e-voting: 19–22 September 2026, 09:00–17:00 IST.
  • Deemed venue: 3rd Floor, Rupam Building, Mumbai.
  • Attendees: 49 members attended virtually.

Key Resolutions

  • Adoption of standalone and consolidated financial statements for the year ended March 31, 2026.
  • Re-appointment of Executive Director for five years with fixed remuneration.
  • Appointment of S.N. Nanda & Co. as Statutory Auditors for five years with remuneration fixed.
  • Ratification of remuneration payable to Cost Auditors for FY 2026-27.
  • Appointment of L. N. Joshi & Co. as Secretarial Auditors through 58th AGM.
  • Approval of material related party transactions.
Filed 19:11View Source
15 Sept 20262 filings
Company UpdateIntimation on Fraud

Mangalam Drugs and Organics declares default on two bank cash credit facilities exceeding 30 days

Default on bank facilities

  • Bank of Maharashtra cash credit account no 60383561246 overdue ₹951.19 Lakh as of 14/09/2026; default began 17/10/2025.
  • Bank of Baroda cash credit account no 04170500000243 overdue ₹606.08 Lakh as of 14/09/2026; default began 20/10/2025.
  • Management is arranging to pay the overdue amounts as soon as possible.
Filed 18:35View Source
Board MeetingOutcome of Board Meeting

Mangalam Drugs appoints Independent Director Prabhakar Raghunath Zavar for five-year term, subject to EGM approval

Independent Director Appointment

  • Appointed Mr. Prabhakar Raghunath Zavar as Independent Non-Executive Director for five years.
  • Term to commence from September 15, 2026.
  • Subject to shareholders' approval at the upcoming Extraordinary General Meeting.
  • Not related to any Directors of the Company.
Filed 16:14View Source
1 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September, 2026 and information on E-voting.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 17:35View Source
Showing 10 of 58 filings